Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RGEN | AVTR |
|---|---|---|
| Price | $189.50 | $15.81 |
| Change today | ▲ 4.29% | ▲ 3.06% |
| Market cap | $10.69B | $10.69B |
| Return, 3 months | +35.5% | +55.0% |
| Return, year to date | +15.6% | +38.0% |
| Return, 1 year | +26.2% | +12.2% |
| P/E (TTM) | 259.6 | -18.6 |
| P/B | 5.1 | 1.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 59 | 64 |
| 30-day volatility | 44.1% | 29.7% |
| Max drawdown, 1 year | -40.3% | -52.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
